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● The aim of this work is to describe and to improve the
production of bisabolene in Saccharomyces cerevisiae using
metabolic engineering.
● Several metabolic engineering techniques and the
metabolic engineering cycle are described.
Bisabolene is the immediate precursor of bisabolane, a fully reduced monocyclic sesquiterpene
which can be obtained by its chemical hydrogenation. Bisabolane can be a biosynthetic alternative
to D2 diesel fuel due to the comparable cold properties, cetane number and carbon length. An
hypothetical economic analysis which estimated ~$6 per gal (more expensive than current D2
diesel) assumed a break-even price of sugar close to $0.10/lb, being $1.76/kg the final cost.
Figure 1. Chemical structures of bisabolane (a) and bisabolene (b). 
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Production of bisabolene in an engineered S. cerevisiae strain was carried out in two steps [1]:
A. S. cerevisiae as an FPP overproduction platform. In this strain the mevalonate
pathway was modified:
1. Overexpression of tHMGR, a truncated HMG-CoA reductase, and integration of an
additional copy.
2. Overexpression of ERG20, the FPP synthase.
3. Overexpression of upc2-1, the global transcription regulator of the sterol pathway.
B. Adaptation of S. cerevisiae for the production of bisabolene. Five bisabolene
synthases (BiS) known in the literature were screened for high bisabolene titers,
and the highest production was achieved using the bisabolene synthase from Abies
grandis.
Plasmid pRS425-Leu2d::BiS was constructed using pRS425, a yeast episomal
plasmid (Yep), as a backbone. Leu2d allele was used, which increases plasmid
copy number in S. cerevisiae due to its weakened expression. This plasmid
contains the 2μ origin of replication, which increases copy number too, and the
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Metabolic engineering is an interdisciplinary field which comprises computational modelling, genetics, biochemistry,
molecular biology, etc. Its main purpose is to redirect the metabolic fluxes to meet the industrial and medical needs.
Its aim is finding what can have failed, understanding the
reasons of this failure and identifying possible targets. It
contains three main points:
1. Fermentation physiology.
2. Metabolic pathway analysis:
a) Identification of metabolic network structure.
b) Quantification of fluxes: FBA.
c) Identification of control structures: MBA.
3. Analytical techniques such as DNA microarrays, northern
Its goal is to design a proper genetic strategy and to apply it to
the initial strain in order to improve it. Improvements can be
applied at three different levels:
a) DNA/gene content: using suitable strains and vectors.
b) Transcription efficiency: Utilising transcription factors and
promoters of different strength.
c) mRNA and translation efficiency: It can be modulated by
antisense RNA and codon usage adaptation. It also takes into
account protein abundance by controlling its concentration.
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● ERG9Figure 2. Representation of the engineered mevalonate pathway for bisabolene production (Adapted from [2] and [3]).
4. Downregulation of ERG8, the squalene synthase.
δ-integration vectors, which allow sequential insertion of multiple cloned genes, were
used to integrate overexpressed genes into the chromosome. These plasmids were
constructed using restriction enzymes and the overexpressed genes were under
control of galactose promoter. pRS-ERG9 was constructed to downregulate ERG9,
which was placed under control of a methionine repressible promoter (PMET3). All
strains were transformed using the lithium acetate method.
REP3 and FRT sequences necessary for high copy propagation in yeast. It also
contains the pMB1 origin of replication, then it can be used in E. coli.
Genes indirectly upregulated:
● ERG13
● ERG12
● ERG8
● Other ergosterol genes.
Figure 3. Plasmid containing BiS under control of the 
Gal1 promoter (Adapted from [4]). 
The bisabolene synthases genes were
amplified from their respective templates
using their respective primers and then
digested with NheI and XhoI restriction sites
to be cloned into the vector. Once screened,
the bisabolene synthase with the highest
production was codon optimized.
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S. cerevisiae as a chassis organism
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blot and mass spectrometry are used to calculate gene,
protein and metabolite expression levels. GC and HPLC
are used to identify these metabolites.
Conclusions and future perspectives
Figure 4. The metabolic engineering cycle (Adapted from [5]). 
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Design of Experiments (DOE) can be useful to design a genetic
strategy. It uses several parameters previously studied, which
provide information about the best parameter combination.
Figure 5. Representation of S. cerevisiae as a chassis organism for the production of different terpenoid products. 
S. cerevisiae is an organism highly preferred by the industry since it can withstand high osmotic pressure
and reduced pH compared to bacteria. In addition, the high efficiency of homologous recombination in this
species has facilitated targeted manipulations within chromosomes. It is also important its classification as
GRAS (Generally Regarded As Safe) by the U.S. Food and Drug Administration (FDA).
This microorganism can be seen as a chassis for the production of different terpenoid products depending
on the genetic design applied. The introduction of a sesquiterpene synthase to this engineered
microorganism has enabled the production of a variety of sesquiterpenes such as drug precursors
(artemisinic acid and patchoulol), terpene-based advanced biofuels (farnesene) and flavour ingredients
(cubebol).
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● Preliminary tests of bisabolane showed that its properties make it a promising biosynthetic
alternative to D2 diesel fuel. Bisabolane can be obtained by chemical hydrogenation of
bisabolene, its immediate precursor.
● S. cerevisiae was engineered to produce bisabolene through metabolic engineering,
which could be used to improve this production. In this work laboratory strains were used,
so it would be necessary to achieve a strain suitable for large scale production to produce
a economically viable biofuel. It was already proved that bisabolene presents no toxicity to
S. cerevisiae.
● A great advance would be adapting S. cerevisiae to lignocellulosic substrates, since these
are cheaper feedstock. The ultimate goal would be the complete microbial production of
bisabolane, which would require the reduction of terpenes in vivo.
